Aethlon Medical Inc (AEMD)

[ANESRI]

Vertex Provides Update on Ongoing All-Oral Studies of VX-135 in Hepatitis C (Increased liver enzymes with high dose - Hopefully awareness of the HP becomes widespread enough that companies start thinking of using it in studies for new drugs. Possibly low dose required for drugs because of low initial viral load, more efficacy for the drug for the same reason, shorter duration i.e fewer weeks for drugs to be administered, more economical ....)

http://investors.vrtx.com/releasedetail.cfm?ReleaseID=780456